Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 24, 2018
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform
Constance Delaby, Laia Muñoz, Soraya Torres, et al.
The Biochemical Journal
|
February 7, 2006
Wild-type and mutant ferroportins do not form oligomers in transfected cells
Ana Sofia Gonçalves, Françoise Muzeau, Rand Blaybel, et al.
Clinical Chemistry and Laboratory Medicine
|
October 24, 2013
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid
Constance Delaby, Audrey Gabelle, Philippe Meynier, et al.
International Journal of Legal Medicine
|
March 19, 2021
Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?
Pierre-Antoine Peyron, Christophe Hirtz, Eric Baccino, et al.
BMC Cancer
|
November 22, 2025
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer
Constance Delaby, Anas Al Herk, Christophe Hirtz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 25, 2024
A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
Etienne Mondésert, Susanna Schraen-Maschke, Isabelle Quadrio, et al.
The Lancet. Healthy Longevity
|
October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's disease
Michael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 9, 2018
Association between serum hepcidin level and restless legs syndrome
Yves Dauvilliers, Sofiene Chenini, Jérôme Vialaret, et al.
Critical Reviews in Clinical Laboratory Sciences
|
October 30, 2019
Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?
Bhavana Veerabhadrappa, Constance Delaby, Christophe Hirtz, et al.
Frontiers in Neurology
|
September 18, 2015
Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach
Constance Delaby, Audrey Gabelle, David Blum, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 24, 2018
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform
Constance Delaby, Laia Muñoz, Soraya Torres, et al.
The Biochemical Journal
|
February 7, 2006
Wild-type and mutant ferroportins do not form oligomers in transfected cells
Ana Sofia Gonçalves, Françoise Muzeau, Rand Blaybel, et al.
Clinical Chemistry and Laboratory Medicine
|
October 24, 2013
Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid
Constance Delaby, Audrey Gabelle, Philippe Meynier, et al.
International Journal of Legal Medicine
|
March 19, 2021
Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?
Pierre-Antoine Peyron, Christophe Hirtz, Eric Baccino, et al.
BMC Cancer
|
November 22, 2025
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer
Constance Delaby, Anas Al Herk, Christophe Hirtz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 25, 2024
A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
Etienne Mondésert, Susanna Schraen-Maschke, Isabelle Quadrio, et al.
The Lancet. Healthy Longevity
|
October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's disease
Michael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 9, 2018
Association between serum hepcidin level and restless legs syndrome
Yves Dauvilliers, Sofiene Chenini, Jérôme Vialaret, et al.
Critical Reviews in Clinical Laboratory Sciences
|
October 30, 2019
Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?
Bhavana Veerabhadrappa, Constance Delaby, Christophe Hirtz, et al.
Frontiers in Neurology
|
September 18, 2015
Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach
Constance Delaby, Audrey Gabelle, David Blum, et al.
Page
of 8